Thai newly diagnosed ALL patients aged greater than 18 years. Acute lymphoblastic leukemia, Next-generation sequencing ,Molecular mutations
Conditions
Interventions
Retrospective and prospective cohort who newly diagnosed ALL patients aged greater than 18 years. who signed consent in Protocol title The newly diagnosed acute lymphoid leukemia registry and ribonu
Diagnostic
Thai newly diagnosed ALL patients aged greater than 18 years
Sponsors
Siriraj Hospital Mahidol University
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1.A retrospective cohort: Thai newly diagnosed ALL patients 2.A prospective cohort: Thai newly diagnosed ALL patients aged greater than 18 years who had genetic workup results by NGS study and signed informed consent OR
Exclusion criteria
Exclusion criteria: Poor quality specimen from a protocol number 388/2561(EC2)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| incidence of molecular mutations in Thai adult newly diagnosed ALL patients by NGS technique 1 years Next-generation sequencing (targeted gene sequencing: Illumina machine) | — |
Secondary
| Measure | Time frame |
|---|---|
| To evaluate the clinical outcome in Thai adult ALL patients considering molecular mutations 1 years Case record form comparing with genetic results by Illumina machine | — |
Countries
Thailand
Contacts
Public ContactWeerapat Owattanapanich
Faculty of Medicine Siriraj Hospital, Mahidol University.
Outcome results
None listed